26 High risk pregnancy assessment Flashcards
4 categories of high risk pregnancy risk factors
Biophysical
Psychosocial
sociodemographic
environmental
Biophysical
AMA genetic disorders nutrition frequent pregnancies (WAIT 18 MONTHS( ABO incompatibility
when to begin monitoring for baby
32-34 weeks until birth
Antepartum testing methods
Biophysical
Biochemical
Electronic Fetal Monitoring
Biophysical methods of monitoring
daily fetal movement counts
ultrasonagraphy
nonmedical ultrasonagraphy
MRI (no full bladder)
Types of ultrasonagraphy
Transvaginal (no full bladder)
abdominal (need full bladder)
Levels of ultrasonagraphy
basic
limited
specialized
Nuchal Transclucency
screening done in ulstrasoud during 10-14 wk that measures nape of fetal neck to determine if greater then 3mm (abnormal); indicates trisomy 13, 18, 21 of cardiac issues
Amniotic fluid volume
determined with ultrasound
Measured by AFI (amniotic fluid index) which can be measured in black space in US
AFI – total # - low of 5 cm to high of 24 cm
AFV= 8-10
amniotic fluid index
5-24 cm
Biophysical Profile (BPP)
Test of fetal well-being that includes AFV, FBMs, fetal movements, and fetla tone by means of NST
Like the stress test, which is US with well-being
Breathing, tone, movements, AFI, NST
Frequent use in 2nd & 3rd trimester
Range of 8-10 with normal AFV is good indicator
Altered if baby is sleeping
- also a modified BPP with AFI
Ultrasound indications
Fetal viability Fetal number and position Gestational age growth patterns Amniotic fluid volume Fetal well being Placental location and condition Cervical length placental position fetal well being crown-rump link (1st trimester) uterine abnormalities
Biochemical methods of monitoring (invasive)
amniocentesis (14 wk)
percutaneous umbilical blood sampling (PUBS)/codocentesis (also anemia, infection, thrombocyopenia)
chorionic villus sampling (CVS) (10-13 wk)
maternal assays
Mother Assays
Maternal serum Alpha-Fetoprotein (MSAFP)
Multiple Marker Screens (also with triple-quad testing with hcG)
Coombs test (Rh incompatibility)
Cell-free DNA screening in Maternal Blood
Nueral tube defects or down syndrome assess
Electronic Fetal Monitoring for antepartum
Use NST or CST
CST through nipple simulation, Oxycontin, or vibroacoustic
NST takes 20-30 min